mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents
S. Rauch, N. Roth, K. Schwendt, M. Fotin-Mleczek, S. O. Mueller, B. Petsch
This study shows that the mRNA vaccine CVnCoV induces strong neutralizing antibodies and protects hamsters from SARS-CoV-2 infection.
bioRxiv · Oct 23, 2020Immunology